Company: BLNE
Filing Date: 2025-01-17
Form Type: PRE 14A
Source: 0001493152-25-002779
Chunk: 118

Company: Beeline Holdings, Inc.
Filing Date: 2025-01-17
Form: PRE 14A
Chunk 118
---
 Amount, which if applicable will apply on a pro rata basis as to the holders thereof so as to preserve the Stated Percentage.

If our common stock is de-listed from Nasdaq, the various shareholder approvals will not be required for conversion and exercise, except for the increase in authorized common stock.

Series G

Each share of Series G has a stated value of $0.51. The holder of Series G has no conversion or voting rights prior to shareholder approval of such actions. In the event of a liquidation of Eastside, the holders of Series G will share in the distribution of Eastside’s net assets on an as-converted basis, subordinate only to the Series B, Series C, Series D and Series E.

If the shareholders of Eastside approve the conversion of the Series G, each share of Series G will be convertible into common stock by a conversion ratio equal to the stated value of the Series G share divided by the Series G conversion price. The initial Series G conversion price is $0.51 per share, subject to adjustment as provided therein including in the event of an issuance of common stock or common stock equivalents at a price per share that is less than the conversion price, subject to a floor price of 20% of the Nasdaq Minimum Price as of the initial closing date of the offering of such Series G. The Series G conversion price is subject to equitable adjustment in the event of a stock split, reverse split and similar events. The number of shares of common stock into which a holder may convert Series G will be limited by a beneficial ownership limitation, which restricts the number of shares of Eastside common stock that the holder and its affiliates may beneficially own after the conversion to 4.99%. Effective immediately upon approval of Proposal 1, the Series G will be eligible to vote, including on the other Proposals being brought before the Special Meeting, subject to any applicable beneficial ownership limitations.

Series G Warrants

Each warrant is exercisable for a five year term at an exercise price of $0.65 per share beginning on the effective date of (i) an increase in authorized common stock of the Company as necessary to permit full issuance of the shares of common stock underlying the warrants and the Series G sold together with other common stock equivalents outstanding and (ii) the approval of the issuance of all of the securities as may be required by the rules and regulations of The Nasdaq Stock Market LLC.

Note Warrants

Each warrant has a term of five years from issuance and are exercisable at an exercise